SCHEMBL13640163

SCHEMBL13640163

COC(=O)C1CCCC(N)C(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.40
▸ ANPEP P15144 5/20 0.37
▸ LNPEP Q9UIQ6 5/20 0.37
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ CHRNB2 P17787 1/20 0.33
▸ CHRNB4 P30926 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ ALOX12 P18054 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ MMP1 P03956 1/20 0.31
▸ MMP13 P45452 1/20 0.31
▸ PPM1B O75688 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ PPP1CC P36873 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8860207 0.90 KMT2A (0.41) KMT2AANPEPLNPEPALOX12NPSR1
SCHEMBL13818365 0.81 KMT2A (0.42) KMT2AANPEPCHRNB2CHRNB4CHRNA3
SCHEMBL13640202 0.78 KMT2A (0.42) KMT2AALOX12NPSR1
SCHEMBL23736270 0.77 KMT2A (0.32) KMT2A
SCHEMBL13640173 0.75 KMT2A (0.49) KMT2AALOX12NPSR1MMP1MMP13
SCHEMBL27423471 0.75 MME (0.43) ANPEPLNPEP
SCHEMBL15727300 0.75 CTSD (0.32) KMT2AANPEPLNPEP
SCHEMBL4939718 0.74 KMT2A (0.42) KMT2ACHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL5026447 0.74 KMT2A (0.42) KMT2ACHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL4939720 0.74 KMT2A (0.42) KMT2ACHRNB2CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8568814-B2 Lanthionine derivatives AJINOMOTO CO., INC. (JP) 2013-10-29 — — US disclosed
US-20120282386-A1 LANTHIONINE DERIVATIVES AJINOMOTO CO., INC. (JP) 2012-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120282386-A1 LANTHIONINE DERIVATIVES CASR, KCNJ5, CALCR KMT2A 1148/4885ANPEP 1895/4885LNPEP 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback